DistaSense(TM) (v1)
Life Detection Technologies · Decision date Sep 25, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for DistaSense(TM) (v1), submitted by Life Detection Technologies of Sunnyvale, California, under 510(k) number K254058. The decision date is 2026-09-25 and the application was received 12/17/2025. The device falls under regulation 870.2300 with classification product code DRT, a subsequent product code of BZQ, and the cardiovascular medical specialty and review panel. A SESE decision is a 510(k) clearance, not a PMA approval.
The FDA summary describes DistaSense as a contactless device intended to measure heart rate and respiration rate in healthy adult patients at rest, for use by healthcare professionals, caregivers and patients, with no patient contact. The record lists a traditional summary type, no third-party review, no combination product status and no authorized predetermined change control plan. The source does not provide performance testing results, comparison predicates or the full indications wording, so the basis for the equivalence finding remains unknown from this material.
Readers should not infer clinical accuracy, comparative performance or current labeling from the clearance alone; the summary excerpts are partial and the underlying decision rationale is not included.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Sep 25, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254058
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Life Detection Technologies
- Product code
- DRT
- Decision code
- SESE
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Monitor, Cardiac (Incl. Cardiotachometer & Rate Alarm).
- Applicant
- Life Detection Technologies
- Product code
- DRT
- FDA device class
- 2
FDA decision timeline
K254058 received
Application receipt date recorded by FDA.
K254058 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DRT
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Circadia Health, Inc. | 510(k) clearance | Oct 15, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Life Detection Technologies
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Sunnyvale, CA
Sources and methodology
- Original FDA record: K254058
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records